Theragen Etex Co.,Ltd. (KOSDAQ: 066700)

Market Cap	109.62B
Revenue (ttm)	241.95B
Net Income (ttm)	26.59B
Shares Out	32.01M
EPS (ttm)	825.05
PE Ratio	4.03
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	49,017
Open	3,445.00
Previous Close	3,440.00
Day's Range	3,390.00 - 3,490.00
52-Week Range	2,800.00 - 5,110.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About Theragen Etex Co.,Ltd.

Theragen Etex Co.,Ltd., together with its subsidiaries, engages in the research and development, production, and sale of pharmaceutical products in Korea. It offers drugs in the fields of circulatory, respiratory, digestive, antibiotics, antifungals, analgesic, endocrine and metabolic, hepatoprotective, psychotropic, urinary system, skeletal muscle, PMS, anthelmintic, nutrition, and others. The company was formerly known as Theragen Co., Ltd. and changed its name to Theragen Etex Co.,Ltd. in July 2010. Theragen Etex Co.,Ltd. was founded in 1987...

• Industry: Special Industry Machinery, not elsewhere classified
• Founded: 1987
• Employees: 202
• Stock Exchange: KOSDAQ
• Ticker Symbol: 066700

Financial Performance

In 2023, Theragen Etex Co.,Ltd.'s revenue was 221.72 billion, an increase of 16.23% compared to the previous year's 190.77 billion. Earnings were 26.21 billion, an increase of 174.14%.